Pink Pussycat Honey recalled for undeclared sildenafil and tadalafil content
Pyramids Wholesale Inc. is recalling Pink Pussycat Honey because it contains undeclared sildenafil and tadalafil and was marketed without FDA approval. The recall affects all lots nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall for a product marketed without required drug approval containing undeclared sildenafil and tadalafil. FDA Class I recalls are assigned minimum severity 4 per the rubric, regardless of reported illnesses.
Plain-English summary
Pink Pussycat Honey, marketed in 20-gram sachets with UPC 7 918750 046557, is being recalled nationwide by Pyramids Wholesale Inc. The recall applies to all lots of this product.
The FDA is recalling the product because it was marketed without an approved new drug application (NDA) or abbreviated new drug application (ANDA). Testing identified that the product contains undeclared sildenafil and tadalafil.
The recall affects consumers nationwide. A total of 149 boxes have been recalled.
Consumers who have obtained Pink Pussycat Honey should discontinue use and contact a healthcare provider if they have used the product.
The recalled product
- Product
- Pink Pussycat Honey, net wt: 20gx12 sachets, UPC 7 918750 046557
- Manufacturer
- Pyramids Wholesale Inc.
- Category
- Drug
- Hazard
- undeclared-sildenafil
- undeclared-tadalafil
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereMG217 Multi-Symptom Treatment Cream recalled for microbial contamination
FDA (Drugs) · 2026-05-27